Amos Bar Shalev
Independent DirectorMr. Amos Bar Shalev has been an Independent Director of Protalix BioTherapeutics, Inc. since July 14, 2008 and previously also served as its Director from December 31, 2006 to January 31, 2008. Since 2011, Mr. Bar Shalev has served on the Board of Directors of Interna Therapeutics Ltd. (formerly, Aposense Ltd.), a privately-held pharmaceutical company. He served as a director of Protalix Ltd. from 2005 through January 2008. He holds experience in managing technology companies. He serves on the Board of Directors of the following privately-held Israeli companies: Aposense Ltd., Twine Solutions Ltd., Steam CC Ltd. and Sirvir Ltd. From 2004 through 2012, he served as a director of Technorov Holdings (1993) Ltd. and managed its portfolio. From 1997 through 2004, he was a Managing Director of TDA Capital Partners, a management company of the TGF (Templeton Tadiran) Fund. He holds the highest award from the Israeli Air Force for technological achievements. He was the President of Win Buyer Ltd since 2004 until 2007. He has served on the Board of Directors of a number of Israeli publicly traded and privately-held Israeli companies including, among others, Velox Ltd., NESS Ltd. (acquired by BioNess Inc.), Idanit (acquired by Scitex Corporation Ltd.), Objet Geometrix (merged with Stratasys, Inc. (NASDAQ:SSYS)), Verisity, Scitex Vision (acquired by Hewlett Packard), Golden Wings Investment Company Ltd., the venture capital fund of the Israeli Air Force Veterans Business Club, Win Buyer Ltd. and Sun Light Ltd. He received his B.Sc. in Electrical Engineering from the Technion, Israel Institute of Technology in 1978 and M.B.A. from the Tel Aviv University in 1981.
Positions
- Company NameProtalix BioTherapeutics, Inc.Stock CodePLXPositionIndependent DirectorColleagues
